Author:
Szczesniak Rhonda,Huang Bin
Reference35 articles.
1. Gliklich RE, Dreyer NA, editors. Registries for Evaluating Patient Outcomes: A User’s Guide. 2nd ed. Rockville, MD: Agency for Healthcare Research and Quality; 2010 (Prepared by Outcome DEcIDE Center [Outcome Sciences, Inc. d/b/a Outcome] under Contract No. HHSA29020050035I TO3); AHRQ Publication No.10-EHC049
2. McGoon MD, Benza RL, Escribano-Subias P, Jiang X, Miller DP, Peacock AJ, et al. Pulmonary arterial hypertension: Epidemiology and registries. Journal of the American College of Cardiology. 2013;62(25 Suppl):D51-D59
3. Lilienfeld M. Epidemiological methods and inferences in studies of noninfectious diseases PHR review. Public Health Reports. 1957;72(1):51-60
4. VanDyke RD, McPhail GL, Huang B, Fenchel MC, Amin RS, Carle AC, et al. Inhaled tobramycin effectively reduces FEV1 decline in cystic fibrosis: An instrumental variables analysis. Annals of the American Thoracic Society. 2013;10(3):205-212
5. Cystic Fibrosis Foundation. Patient Registry: 2012 Annual Report; 2013